benzimidazol-2-one has been researched along with lysine in 1 studies
| Studies (benzimidazol-2-one) | Trials (benzimidazol-2-one) | Recent Studies (post-2010) (benzimidazol-2-one) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 18 | 0 | 9 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | benzimidazol-2-one (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chimirri, A; Crespan, E; Logoteta, P; Maga, G; Monforte, AM; Samuele, A; Vitellaro, S | 1 |
1 other study(ies) available for benzimidazol-2-one and lysine
| Article | Year |
|---|---|
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.
Topics: Amino Acid Substitution; Asparagine; Benzimidazoles; Cell Line; Cell Survival; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mutant Proteins; Mutation, Missense; Protein Binding; Reverse Transcriptase Inhibitors | 2010 |